{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-098340","form_type":"8-K","ticker":"SPRB","cik":"0001683553","company_name":"SPRUCE BIOSCIENCES, INC.","filed_at":"2025-07-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.640285+00:00","generated_at":"2026-05-18T02:23:42.965409+00:00","sec_items":["3.03","5.03","5.07","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Spruce Biosciences to effect 1-for-75 reverse stock split on Aug 4 to regain Nasdaq compliance","bullets":["Reverse stock split effective 5:00 p.m. ET on August 4, 2025; shares trade split-adjusted on OTC Pink on August 5.","Outstanding shares reduce from ~42.2M to ~0.6M; no fractional shares issued, cash payments in lieu.","Stock will return to Nasdaq Capital Market if minimum bid price is met for 20 consecutive trading days after effective date.","Stockholders approved reverse split at annual meeting on July 22; board set ratio at 1:75."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-098340","json":"https://secwatch.observer/filing/0000950170-25-098340.json","markdown":"https://secwatch.observer/filing/0000950170-25-098340.md","text":"https://secwatch.observer/filing/0000950170-25-098340.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1683553/000095017025098340/0000950170-25-098340-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1683553/000095017025098340/sprb-20250722.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T02:23:42.965409+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"060d49642c5a2daab89d5eca60604de5b055e1d5","claim":"SPRUCE BIOSCIENCES, INC.: Amendment to Certificate of Incorporation to effect a 1-for-75 reverse stock split (effective 2025-08-04).","evidence_excerpt":"On July 23, 2025, Spruce Biosciences, Inc., a Delaware corporation (the “Company”), filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Amendment”) to the Company’s Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), to effect a one-for-seventy-five (1:75) reverse stock split of its outstanding common stock, effective as of August 4, 2025 (the “Reverse Stock Split”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1683553/000095017025098340/0000950170-25-098340-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-08-04"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}